The Recall Desk
SevereFDA (Drugs)·D-864-2015·Announced 2015-04-29

Attix Pharmaceuticals Recalls Procaine HCl Due to Penicillin Cross-Contamination Risk

Attix Pharmaceuticals is recalling Procaine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination. The product was distributed to compounding pharmacies and research organizations.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric, particularly given the risk of penicillin cross-contamination which can cause severe allergic reactions.

Plain-English summary

Attix Pharmaceuticals is recalling all lots of Procaine HCl active pharmaceutical ingredient that were repackaged and distributed between January 5, 2012, and February 12, 2015. The recall is being conducted because the product was repackaged in a facility that also handled penicillin products without adequate separation, creating a potential for cross-contamination with penicillin.

The affected product is packaged in varying grams or kilograms in bags or drums. The total quantity involved is 4,575 grams. The product was distributed nationwide to compounding pharmacies and research organizations.

Consumers and healthcare providers should stop using the recalled product and contact their supplier or the recalling firm for instructions on return or disposal. This recall is classified as Class II by the FDA, indicating a reasonable probability that use of the product may cause temporary or medically reversible health consequences.

The recalled product

Product
Procaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 470 recalled by Attix Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 470 products in this recall →